---
figid: PMC3552454__nihms434473f4
figtitle: Advances in graft-versus-host disease biology and therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- gut metagenome
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC3552454
filename: nihms434473f4.jpg
figlink: /pmc/articles/PMC3552454/figure/F4/
number: F4
caption: The pathways inside the circle shows the most important pathophysiological
  pathways in the generation of aGVHD. The boxed outside the circle are some of the
  promising categories of therapeutic interventions and their most relevant immunological
  targets in GVHD. Plus signs represent the stimulatory effects and the minus signs
  represent the inhibitory effects of the therapeutics on a pathway.
papertitle: Advances in graft-versus-host disease biology and therapy.
reftext: Bruce R. Blazar, et al. Nat Rev Immunol. ;12(6):443-458.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7157537
figid_alias: PMC3552454__F4
figtype: Figure
redirect_from: /figures/PMC3552454__F4
ndex: ab6eace5-df31-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3552454__nihms434473f4.html
  '@type': Dataset
  description: The pathways inside the circle shows the most important pathophysiological
    pathways in the generation of aGVHD. The boxed outside the circle are some of
    the promising categories of therapeutic interventions and their most relevant
    immunological targets in GVHD. Plus signs represent the stimulatory effects and
    the minus signs represent the inhibitory effects of the therapeutics on a pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Apcs
  - Apc
  - Myd88
  - Nod2
  - Il2
  - Tnf
  - Il21
  - Notch1
  - Stat1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - APCS
  - APC
  - PROC
  - MYD88
  - NOD2
  - IRF6
  - IL2
  - TRE-TTC3-1
  - TREH
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - TNF
  - IFNA1
  - IL22
  - IL21
  - IL1B
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - STAT1
  - Tlr4
  - .na.character
  - Ifnl3
  - Il1
  - hop
  - bsk
  - Apc2
  - Axn
  - Fs(3)Apc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Low
  - tre
  - Gr5a
  - Treh
  - Tre1
  - as
  - dc
  - egr
  - JIL-1
  - rapamycin
---
